Answers are grounded in this paper and cite their sources.
Detailed validation of the preanalytical steps affecting miRNA detection and quantification is critical when considering the use of individual miRNAs as clinical biomarkers. Unless these causes of imprecision are considered and mitigated, only miRNAs that are extremely up- or downregulated will be suitable as clinical biomarkers.
No takes yet. Share an insight, caveat, or question.
McDonald et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: